4/A
Changes in Ownership
BRAINSTORM CELL THERAPEUTICS INC. Filed Acc 0001104659-24-084341
President & CEO bought 40,000 shares at an average $0.47 ($18,865)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/tm2420560-5_4aseq1.xml…